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Abstract
Cognitive Bias Modification (CBM) refers to a family of interventions targeting substance-related cognitive biases, which have
been found to play a role in the maintenance of addictive behaviors. In this study, we conducted a Bayesian meta-analysis of
individual patient data from studies investigating the effects of CBM as a behavior change intervention for the treatment of
alcohol and tobacco use disorders, in individuals aware of the behavior change goal of the studies. Main outcomes included
reduction in the targeted cognitive biases after the intervention and in substance use or relapse rate at the short-to-long term
follow-up. Additional moderators, both at the study-level (type of addiction and CBM training) and at the participant-level
(amount of completed training trials, severity of substance use), were progressively included in a series of hierarchical mixed-
effects models. We included 14 studies involving 2435 participants. CBM appeared to have a small effect on cognitive bias (0.23,
95% credible interval = 0.06–0.41) and relapse rate (−0.27, 95% credible interval = −0.68 – 0.22), but not on reduction of
substance use. Increased training practice showed a paradoxical moderation effect on relapse, with a relatively lower chance
of relapse in the control condition with increased practice, compared to the training condition. All effects were associated with
extremely wide 95% credible intervals, which indicate the absence of enough evidence in favor or against a reliable effect of
CBM on cognitive bias and relapse rate in alcohol and tobacco use disorders. Besides the need for a larger body of evidence,
research on the topic would benefit from a stronger adherence to the current methodological standards in randomized controlled
trial design and the systematic investigation of shared protocols of CBM.
Keywords Alcohol .Tobacco . Smoking .Cognitive biasmodification .Behavior change intervention .Meta-analysis .Bayesian
meta-analysis
Introduction
In the past decade, a new family of neurocognitive training
paradigms, collectively called Cognitive Bias Modification
(CBM), has received increasing attention as a potential low-
threshold and easy-to-administer group of adjunct interven-
tions for the treatment of addictive behaviors. CBM includes
a variety of computerized training paradigms aimed at inter-
fering with attentional, behavioral, or evaluative cognitive
processes triggered by addiction-related cues in the environ-
ment. These cognitive biases have been found to play a role in
maintaining addictive behaviors (for a review, see Wiers et al.
2013), leading researchers to the development of tools that
could effectively modify these biases and, in turn, advance
the treatment of addiction.
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Typically, CBM training paradigms are based on the same
methods used to assess the target cognitive bias, that is, speeded
reaction-time tasks where participants have to react to disorder-
relevant and control stimuli presented with some form of
stimulus-response contingency (e.g., bias scores comparing re-
sponses for two task contingencies, such as responses toward or
away from addiction-relevant stimuli). When the original as-
sessment task is adapted for training, the built-in stimulus-re-
sponse contingency is manipulated in order to create, through
repeated practice, a new dominant stimulus-response associa-
tion competing with, and counteracting, the existing dominant
response toward the addiction-relevant cues. For example, in
order to manipulate selective attention towards motivationally
salient substance-related cues (i.e., attentional bias), researchers
adjusted the Visual Probe Task (MacLeod et al. 1986). In this
task, participants have to respond to a probe presented at the
location of one of two stimuli displayed next to each other (or
on top of each other) on the computer screen, such as a picture
of a package of cigarettes and a smoking-unrelated picture. In
the assessment version of the task, the probe is presented equal-
ly often at the location previously occupied by both types of
stimuli. Typically, participants respond faster when the probe
appears at the location on which their attention was already
focused (Posner et al. 1980), that is, in the case of smokers,
on the smoking-related stimulus. In the version of the task used
to deliver Attentional Bias Modification (Field et al. 2007;
MacLeod et al. 2002; Schoenmakers et al. 2007), the
stimulus-response contingency is manipulated so as to system-
atically present the probe at the location of the neutral stimulus,
thus training participants to consistently shift attention away
from substance-related cues and to attend to neutral cues in-
stead. The underlying idea is that repeated training can reduce
or even invert the targeted biases, which in turn should lead to
or help behavioral change (Wiers et al. 2013).
Similar contingencies have been introduced in other tasks
used to assess different biases, such as the Approach
Avoidance Task (Rinck and Becker 2007; Wiers et al. 2009),
which is aimed at capturing approach action tendencies to-
wards substance-related cues and has been modified to deliver
Approach Bias Modification training (Wiers et al. 2010,
2011); the Go/No-Go task, which has been modified with
the goal of inhibiting an instrumental response or behavioral
approach towards reward-related cues (Selective Inhibition
Training SIT , Houben et al. 2010a; for a meta-analysis, see
Allom et al. 2016 and Jones et al. 2016) or Evaluative
Conditioning training to change evaluative associations
(Houben et al. 2010b, 2011; Zerhouni et al. 2018).
CBM training paradigms could be executed from the pa-
tient’s own home, potentially enhancing clinical outcomes at
a minimum cost in terms of time and effort for both patients and
health care professionals. The appeal of such computerized
forms of cognitive training has led to both a proliferation of
experimental research on the theoretical underpinnings of
CBM and its short-lived effects, and to the first systematic
evaluations of the therapeutic effects of CBM as a complemen-
tary clinical treatment aimed at behavior change. For a narrative
review of the two classes of studies, seeWiers et al. (2018). The
fewmeta-analyses conducted on the topic concluded that CBM
has very small to no significant effects on the targeted bias(es),
substance use, or symptoms of addiction (Cristea et al. 2016;
Mogoaşe et al. 2014). However, both meta-analyses did not
distinguish between the two qualitatively different classes of
studies, and pooled the results in the same analyses. One class
involves fundamental mechanism-oriented studies typically in-
cluding participants not affected by substance use problems
and not motivated to change their addictive behavior. The other
class includes effectiveness studies and randomized controlled
trials in clinical and subclinical populations.
Although from a pragmatic point of view pooling results
across all CBM studies would provide a broad overview of
the state of affairs of CBM as a research field, the meta-
analytic blending of more fundamental and proof-of-
principle studies and effectiveness studies in clinical and
subclinical samples may lead to imprecise and misleading
estimations about the clinical efficacy or effectiveness of
CBM as a treatment method (Wiers et al. 2018). The for-
mer proof-of-principle studies have the primary goal of
testing causal hypotheses on the relation between targeted
cognitive biases and short-lived changes in behavior,
typically with a taste-test, in participants not suffering from
the target disorder (typically students), while the latter spe-
cifically target the population affected by the disorder of
interest and are explicitly aimed at behavior change.
Although fundamental research does and should provide
evidence and suggestions for further clinical applications
of behavior change principles, it is not meant nor designed
to evaluate the therapeutic effects of such principles imple-
mented into a behavior change treatment program (Sheeran
et al. 2017; Wiers et al. 2018).
The goal of this meta-analysis was to quantify the existing
evidence on the effectiveness of CBM for addictive behaviors
as a behavior change intervention. Therefore, the meta-
analysis exclusively focused on studies evaluating the clinical
effects of any kind of CBM intervention targeting cognitive
biases in problematic alcohol or tobacco use. Studies were
included if designed with the explicit goal of inducing behav-
ior change, excluding proof-of-principle studies in partici-
pants without the shared goal of behavior change. We only
included behavior-change CBM studies in the alcohol and
tobacco addiction domains since at the time of the initial lit-
erature search (May 2016) there was no published report of
CBM intervention studies for other substances (e.g., cannabis,
cocaine, or opiates), but solely cross-sectional assessment
studies of different types of cognitive biases (e.g., Cousijn
et al. 2011; Hester et al. 2006; Field et al. 2006; Lubman
et al. 2000; Zhou et al. 2012).
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Furthermore, conventional study-level systematic reviews
often lack adequate power to detect clinically relevant predic-
tors and moderators of treatment outcomes as effect size esti-
mates are heavily dependent on the sample size of the individ-
ual clinical studies, which themselves can be underpowered.
Therefore, this meta-analysis used individual patient data from
the included studies instead of study-level aggregated esti-
mates of effect sizes as to maximize the use of all available
evidence to detect a true effect and explore study variability
(e.g., type of targeted addiction, type of CBM intervention,
intervention setting) and participants characteristics (severity
of substance use problems and training adherence in terms of
amount of completed training trials) as moderators of primary
CBM outcomes (i.e., change in the target cognitive bias and
substance use behavioral outcomes, such as reduction in sub-
stance use or relapse rate).
Although individual patient data meta-analyses are a pow-
erful instrument for a more comprehensive analysis of all
available evidence, providing deeper insight into the mecha-
nisms underlying an effect, they are not to be taken lightly as
they require a careful evaluation of the necessary workflow
and expertise upfront. Individual patient data meta-analyses
are more complex and challenging than conventional meta-
analyses. These methods are more time and resource inten-
sive since they are dependent on retrieving the individual
patient data from researchers and on establishing an often
long-lasting back-and-forth communication with researchers
regarding the individual patient data and any missing or dis-
crepant information found during the data checking. Indeed,
it took around 1.5 years and an intense communication with
the respective first authors in order to retrieve the raw datasets
of the studies included in our meta-analysis, partially due to
the very sensitive and confidential nature of clinical data.
Further, individual patient data meta-analyses require making
complex decisions about data handling in order to ensure the
accuracy of outcomes (e.g., how to harmonize different out-
come measures across studies or how to handle missing data)
and advanced statistical expertise due to the complexity of the
hierarchical modeling involved.
Our meta-analytic approach involved testing a series of
multilevel mixed-effects models including relevant study-
and participant-level moderators on the pooled individual pa-
tient data from all studies. All models were tested within the
Bayesian statistical framework in order to benefit from the
advantage of quantifying the available evidence in favor or
against a hypothesized effect, outweighing some of the limi-
tations of the classic frequentist approach. Statistical inference
in the frequentist approach typically relies on a p-value, that is,
the conditional probability that the observed data (i.e., p(data |
hypothesis), H0) – or more extreme data – may be observed
under the assumption that the null hypothesis of a zero effect,
is true. While this is the favored standard approach in behav-
ioral and cognitive science, it suffers from several limitations.
First, the p-value does not provide information on the prob-
ability of the tested hypothesis H1 and hence does not allow
for a direct corroboration of the hypothesis of interest. In the
frequentist approach, it is not possible to estimate the proba-
bility of the hypothesis being true given the data, or p-
(hypothesis H1 | data). Because p(hypothesis H1 | data) can
be weakly correlated to p(data | hypothesis H1), (r = .38,
Krueger 2001; Krueger and Heck 2017), the p-value does
not allow us to directly draw any inference about the hypoth-
esis. The casual inference from p(data | hypothesis H1) to p-
(hypothesis H1 | data) has therefore little justification. Second,
the p-value has been shown to have a high sampling variation,
depending on effect size, sampling variability, and sample size
(Murdoch et al. 2008; Cumming 2014). Third, as samples
become very large, even small deviations from the null hy-
pothesis have a higher probability of passing the significance
threshold, since an increase in sample size decreases standard
error (Kruschke 2013; Kruschke and Lidell 2017).
In contrast to classical methods, which cannot distin-
guish between the absence of evidence (i.e., the data are
uninformative) and the evidence of absence (i.e., the data
support the null hypothesis H0), Bayesian methods allow
modeling and quantification of the evidence for each hy-
pothesis, rather than relying on a dichotomous decision
(Wagenmakers et al. 2018). This is why we conducted
the meta-analysis within the Bayesian framework, using a
hierarchical random-effects modeling approach similar to
that of Marsman et al. (2017). In this approach, informa-
tion about the effect can be estimated from the individual
participants nested within individual studies – similar to
the frequentist approach – but yielding posterior distribu-
tions for the effect sizes. Individual effect sizes from each
study are therefore not considered alone, rather, they are
assumed to be drawn from a group-level normal distribu-
tion of effect sizes (i.e., the group-level model), whose
variance and mean reflects heterogeneity between studies
and the mean effect size in the group of studies. Further,
the hierarchical structure of the group-level model shrinks
individual results that are uncertain and relatively extreme
to the group mean effect (Efron and Morris 1977; Lee and
Wagenmakers 2014), and it is generally possible to obtain
narrower posterior credible intervals since the uncertainty of
the individual study effects are reduced by the information
borrowed from other statistically similar studies. Finally,
Bayesian hypothesis testing allows us to explicitly quantify
the evidence in favor of the null hypothesis versus a specific
alternative hypothesis (i.e., Bayes factor; Marsman et al. 2017;
Wagenmakers et al. 2018).
Although providing a compelling framework to test al-
ternative hypotheses, Bayesian methods also suffer from
important downsides. It could also be argued that the pos-
sibility of including prior information is an advantage (e.g.,
Vanpaemel 2010), however, a common criticism is that the
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Bayes factor is sensitive to the choice of the prior distribu-
tion of model parameters, consequently influencing the
statistical inference regarding the plausibility of a certain
model over another. We therefore evaluated the robustness
of the conclusions across three different prior distributions.
Another, more pragmatic, downside of utilizing a Bayesian
approach includes the difficulties in the specification of the
model(s) to be tested since it is not possible, nor feasible to
test all possible models included in a parameter space, and
the need for very high computational power with standard
software.
The present study reported the results of a Bayesian
meta-analysis of behavior change studies evaluating the
effectiveness of any kind of CBM intervention with partic-
ipants suffering from alcohol and tobacco use disorders or
problems. The main goal was to establish a) whether CBM
interventions impact the targeted cognitive bias(es) and
substance use outcomes (i.e., reduction in substance use
and relapse rate) , and b) i f relevant s tudy- and
participant-level characteristics moderate these effects.
Characteristics examined included targeted substance use
disorder, type of CBM training deployed in the interven-
tion, intervention setting, amount of completed training
trials, and severity of substance use problems.
Methods
Study Eligibility Criteria
Studies were included if they met the following eligibility
criteria: (1) were published in English, (2) included a CBM
intervention directed at alcohol or tobacco use, for example,
Approach Bias Modification (e.g., Wiers et al. 2010, 2011),
Attentional Bias Modification (e.g., Field et al. 2007;
Schoenmakers et al. 2007), Evaluative Conditioning or
Selective Inhibition Training (e.g., Houben et al. 2010a, b,
2011);, (3) included outcome measures of cognitive bias, sub-
stance use, or relapse rate;, (4) participants were randomly
allocated to intervention conditions, (5) included a compari-
son between a control condition (active or inactive) and a
CBM intervention (studies that featured multiple control con-
ditions or interventions were also included), and (6) partici-
pants were aware that the goal of the study was behavior
change (e.g., abstinence, reduction of substance intake or of
addiction problems). The latter criterion was added to distin-
guish clinical effectiveness and behavior change CBM studies
from more fundamental proof-of-principle lab-studies
(Sheeran et al. 2017), which are aimed at experimentally ma-
nipulating target psychological processes in order to establish
causality, and not to evaluate the effects of an intervention for
a particular condition (for a more extensive discussion on this
distinction in the CBM field, see Wiers et al. 2018).
Study Identification and Selection Process
The meta-analysis was performed in compliance with the
Preferred Reporting Items for Systematic Review and Meta-
analysis (PRISMA) individual patient data Statement (Stewart
et al. 2015). PsychINFO, Medline, Web of Science, Embase,
and the Cochrane Library bibliographic databases were sys-
tematically searched from inception to May 18, 2016. Three
sets of keywords were used covering the constructs of interest,
namely, cognitive bias, addiction, and study type. For the cog-
nitive bias set the main keywords were “cognitive bias”, “at-
tentional bias”, “approach bias”, “response inhibition”. The
second group of keywords related to addiction included “al-
cohol”, “drinking” and “tobacco”. The third group of key-
words covering intervention types consisted of “longitudinal”,
“(re)training”, “intervention” and “task”. All sets of keywords
and subject headings for all databases were compiled with the
support of the health librarian of the University of Amsterdam.
They were generated both from a set of relevant keywords
compiled by two CBM researchers and using a reference set
of articles known to the authors as meeting the inclusion
criteria. For all sets, additional keywords were used based on
the bibliographic categorization of relevant papers reporting
behavior-change CBM studies. The full list of search strings
and results per bibliographic database is reported in the
Supplementary Material. The references of the included stud-
ies were also searched systematically for missed studies. Two
of the authors independently examined titles and abstracts of
2579 search results and further screened the full text of poten-
tial studies for full eligibility. In case of unclear or missing
information to decide upon inclusion, the first authors of the
candidate studies were contacted. Criterion 6 was evaluated
by screening the full-texts for information regarding whether
participants were fully informed about the behavior change
goal of the study (i.e., that they would receive a treatment
intervention). When unclear or no available information was
given, first authors were explicitly asked to clarify what
information was provided to the participants about the
study goals. In case of disagreement regarding inclusion,
consensus was sought through discussion with other two
members of the team expert in CBM and addiction clini-
cal research (MB and KN).
Data Collection and Data Items
Authors of eligible articles were contacted for permission to
use their raw data sets. They were asked to provide individual
raw data on demographic (age and gender), clinical (severity
of substance use problems), and intervention characteristics,
including information regarding randomized group, baseline,
post-intervention, and follow-up total scores of outcomes
(cognitive bias(es), substance use, relapse), and training ad-
herence information (total number of training sessions
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completed * amount of training trials per session). Integrity of
the data included in the collected datasets was screened
against data reported in the published reports and when dis-
crepancies were found, the first authors were contacted for
clarifications.
We also coded study-level variables, which were available
from the full reports, including, targeted addiction, type of
CBM intervention, type of control condition (active or inac-
tive), intervention setting (supervised, such as lab or clinic, or
unsupervised, such as online), assessment time points, and
types of outcomes measures for cognitive bias, substance
use, and relapse rate.
The analyses were conducted separately for each outcome,
that is, cognitive bias, reduction in substance use, and relapse
rate. The selection of moderator variables, and interactions
between moderators, has been based on literature related to
moderators of CBM training effects (i.e., severity of substance
use problems; Eberl et al. 2013; intervention setting, Price
et al. 2016) and hypotheses regarding intervention parameters
that can impact effectiveness (i.e., type of CBM training and
training adherence in terms of amount of completed training
trials).
Risk of Bias Assessment in Individual Studies
We examined the risk of bias in the included studies using
the criteria of the Cochrane Collaboration risk of bias
assessment tool (Higgins et al. 2011). Two of the authors
independently evaluated the included studies to determine
whether there was a risk for bias related to selection,
performance, detection (for cognitive bias and behavioral
outcomes), attrition (for cognitive bias and behavioral
outcomes), and reporting. In case of unclear risk of bias
for one or more key domains, the first authors of the
included studies were contacted for clarifications.
Individual Patient Data Meta-Analysis
Included studies used a mixture of measures to assess the
study outcomes, that is, reaction-time tasks for the targeted
cognitive bias(es) and self-report measures of substance use
during a defined time frame (see Table 1). Cognitive biases are
always assessed with reaction-time tasks involving the presen-
tation of substance-related cues (typically pictures) across tri-
als involving a stimulus-response manipulation, for example,
alcohol-related and non-alcohol-related stimuli are presented
in both approach and avoid trial formats in the Approach
Avoidance Task in order to assess approach bias towards the
alcohol-related relative to the non-alcohol-related cues.
Another example includes the presentation of a probe
appearing at the location of either the alcohol-related or the
non-alcohol-related stimulus in the Visual Probe Task in order
to assess attentional bias. A summary score is typically
obtained by computing the relative difference in mean (or
median) response times (RT) to substance-related stimuli pre-
sented in the different trial conditions (e.g., [alcohol/avoid –
alcohol/approach] – [non-alcohol/avoid – non-alcohol/ap-
proach] for approach bias, or probe/non-alcohol – probe/
alcohol for attentional bias). Such scores index the strength
of cognitive bias towards substance-related stimuli relative to
control stimuli (e.g., the difference in RT between ap-
proaching rather than avoiding alcohol-related cues and ap-
proaching rather than avoiding non-alcohol-related cues). The
scoring logic is the same across the different paradigms be-
longing to this family of neuropsychological tasks. Therefore,
cognitive bias scores were standardized within each study by
transforming them into z scores, which has the added benefit
of removing any confounder related to using, for example,
slightly different task data cleaning procedures, or using mean
or median RT scores.
Given that the same assessment task is normally recast for
training, some studies included the evaluation of training ef-
fects on the targeted bias, or on a different type of cognitive
bias, by also assessing it with an additional, different task
paradigm (i.e., Begh et al. 2015; Eberl et al. 2013;
Schoenmakers et al. 2010; Wiers et al. 2011). This approach
has the advantage of detecting whether training effects gener-
alize beyond the same task paradigm, that is, “far generaliza-
tion”, which is different from “close generalization”, referring
to an effect on untrained stimuli in the same task used for
training (Wiers et al. 2013). Hence, when different measures
of cognitive biases were used, all were included in the indi-
vidual patient data analysis as a separate comparison.
The same z-score transformation was applied to measures of
substance use, all of which consisted of similar retrospective,
calendar-based measures of consumption during a defined time
window (e.g., the Time Line Follow Back or questionnaires
assessing quantity and/or frequency of substance use over a
defined time window, usually one or two weeks; see Table 1).
Hence, there was no substantial difference in the type of mea-
sure of substance use across studies preventing the application
of a z-score transformation. Before standardizing the substance
use measures, they were adjusted so as to index the average
quantity of substance consumption per week, allowing for a
direct comparison of training effects across the studies.
Therefore, when weekly scores were not directly available,
individual measures of tobacco use (i.e., number of cigarettes
per day) were multiplied by seven in order to align them to the
time window typically used in alcohol studies (i.e., amount of
alcohol units or drinks per week). To do so, we also had to
adjust one alcohol study by multiplying the alcohol-use out-
come (i.e., mean number of drinks per day) by seven (Wiers
et al. 2015b).
One of the moderators, severity of substance use problems,
was also assessed differently across studies. Studies in the
tobacco domain all used the same instrument to assess severity
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of smoking addiction (Fagerström Test for Nicotine
Dependence, FTND; Heatherton et al. 1991). However, while
most studies targeting alcohol addiction assessed severity with
the Alcohol Use Disorder Identification Test (AUDIT;
Saunders et al. 1993), two studies (Clerkin et al. 2016; Cox
et al. 2015) used two other self-report measures, the Drinker
Inventory of Consequences (Miller et al. 1995) and the Short
Index of Problems (Feinn et al. 2003), respectively, with the
latter being a short version of the former, therefore highly
related to each other. These two measures of alcohol problems
have shown to be moderately-to-highly associated with the
AUDIT, supporting the idea that they conceptually measure
similar constructs (Donovan et al. 2006). Therefore, they were
also included in the moderation analyses for severity of sub-
stance use. Before conducting the analyses, all measures of
severity of substance use were standardized by transformation
into z scores across studies using the same measure (four for
the AUDIT, one for the Drinker Inventory of Consequences
and one for Short Index of Problems, seven for the FTND; one
study did not include individual patient data on severity of
substance use problems). All other moderator variables were
standardized within each study before running the analyses.
Most of the studies included multiple assessment time
points of both cognitive bias and substance use outcomes.
However, to minimize the spread of difference in the follow-
up duration, for all studies we included the first cognitive bias
measurement available after the conclusion of the training. For
substance use and relapse rate we included the measurements
taken at the longest follow-up time point available. A
duration-of-follow-up variable measured in weeks from the
end of training was extracted from the study reports or the
datasets including individual patient data, standardized within
each study, and added in the main analyses as a covariate.
Note that for one study the duration of the longest follow-up
was slightly different across participants (range = 19–
26 weeks; Elfeddali et al. 2016), therefore for this study we
computed the mean duration of follow-up across participants
(mean = 24).
For all studies, we contrasted the CBM intervention with
the control condition. One study included two control condi-
tions (Wiers et al. 2011), which were collapsed to avoid the
exclusion of a substantial amount of observations, and were
reported not to be different on any of the outcomes. If a study
contained multiple CBM conditions or multiple measures for
the same outcome, all conditions and outcomes were included
in the analysis as separate comparisons. Note that two studies
tested the combination of a CBM intervention with a different
intervention with a factorial experimental design (Clerkin
et al. 2016; Cox et al. 2015). For these studies, the relevant
CBM training and control groups were collapsed over the
other intervention levels. We also collapsed together the dif-
ferent Approach Bias Modification training conditions in
Wiers et al. (2011), Wiers et al. 2015b) and Wittekind et al.
(2015), since the training varieties administered to the groups
only differed slightly, with no substantial difference in training
effects in intention-to-treat analyses.1 Finally, due to the orig-
inal study design comparing multiple CBM trainings against
the same control condition, the Attentional Bias Modification
and Approach Bias Modification training conditions in Wiers
et al. (2015a, b) were each contrasted against the same control
group in the analyses.
Missing outcome data was not estimated with imputation
methods when the authors did not use one, that is, imputed data
were used only when available in the original raw datasets.
Note that, when including non-completers in the analyses, dif-
ferent missing data imputation methods were used across the
studies, including single (i.e., last observation carried forward;
Cox et al. 2015; Machulska et al. 2016; Schoenmakers et al.
2010) and multiple imputation (Wiers et al. 2015b), and the use
of statistical methods robust to missing data, such as multilevel
mixed models (Begh et al. 2015; Clerkin et al. 2016).
For each outcome, a one-stage individual patient data meta-
analysis was conducted and all individual raw data sets were
combined into a merged data set, with participants nested
within studies. A series of meta-regression analyses was con-
ducted on each of the three outcomes (n = 18 comparisons for
cognitive bias, n = 7 comparisons for reduction in substance
use and n = 8 comparisons for relapse), testing seven hierar-
chically organized models of increasing complexity against a
base model (M0), which included only the main effect of train-
ing condition (i.e., training or control). The goal was to test
whether study-level (duration of the follow-up measurement,
type of CBM training and addiction disorder) and available
participant-level (severity substance use problems and number
of completed training trials)2 characteristics moderated the
effects of CBM on the considered outcomes.
1. M0: training condition (i.e., training or control)
2. M1: M0 + duration of follow-up covariate
1 All studies used the Approach Avoidance Task task to deliver the training. In
Wiers et al. (2015a, b), one version of the Approach Bias Modification explic-
itly instructed participants to react to alcohol-related and non-alcohol-related
stimuli, while the other two varieties implicitly instructed participants to react
to the stimulus format in 90 and 100% of the trials, respectively. In ITT
analyses, the three Approach Bias Modification conditions did not show any
significant difference in the effect on drinking reduction at follow-up.
Therefore, they were merged together for the current meta-analysis similar to
Wiers et al. (2011), where no difference in training effects was found between
explicit and implicit instructions. Similarly, in Wittekind et al. (2015), an
additional Approach Bias Modification condition presented an adjusted ver-
sion of the Approach Avoidance Task training presenting RT feedback at the
end of each trial. Although this version underperformed the standard training
in per-protocol analyses, both of them showed a significant reduction in the
substance use outcome at follow-up in the ITT results.
2 Due to the small amount of observations, training setting (supervised, such as
clinic or research lab, and unsupervised, such as online) was not included as a
moderator in the models. The large majority of studies were conducted in
supervised settings, providing too few observations to evaluate moderation
effects of setting (i.e., very small variance in the moderator).
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3. M2: M1+ addiction disorder (i.e., alcohol or tobacco)
4. M3: M2+ type of CBM training (i.e., Attentional Bias
Modification or Approach Bias Modification)
5. M4: M3+ addiction disorder * type of CBM training
6. M5: M4+ No. of completed training trials
7. M6: M5+ No. of completed training trials * training
condition
8. M7: M6+ severity of substance use problems
Control and training condition were coded −0.5 and + 0.5,
respectively. Alcohol use disorder and Attentional Bias
Modification training were coded −1 and tobacco use disorder
and Approach Bias Modification training +1.
Bayesian Individual Patient Data Meta-Analysis
The Bayesian analyses comprised two steps: (a) estimating the
posterior distributions of the model parameters, and (b) com-
puting the Bayes factor to compare a model against the base-
line model M0.
In Bayesian parameter estimation, observed data are
used to update knowledge about the model parameters
(Wagenmakers et al. 2018). To this aim, we need to specify
our knowledge about the model parameters before the data
are observed by introducing a prior distribution that ex-
presses prior knowledge or the relative plausibility of the
possible values of the parameters. The information in the
data is then used to update this prior distribution to a pos-
terior distribution, which expresses our uncertainty about
the unknown parameters after the data have been observed.
The posterior distributions for the parameters of our
models were estimated with R (R Core Team 2017) using
the rstan package (Stan Development Team 2017). To
summarize these posterior distributions, we report posteri-
or means to indicate the strength of an effect, and 95%
central credible intervals to indicate the uncertainty that
is associated with the effect. If such an interval ranges
between two values a and b, we can be 95% confident that
the true value of the parameter lies between these values.
To compare the predictive accuracy of different models
we use Bayes factors (e.g., Etz and Wagenmakers 2017). A
Bayes factor for comparing M1 against M0, say, is
expressed as
BF10 ¼ p datajM 1ð Þp datajM0ð Þ ;
where p(data | M1) is the marginal likelihood of M1. The
Bayes factors were computed in R using the Savage-
Dickey density ratio representation (Dickey and Lientz
1970; Wagenmakers e t a l . 2010) and using the
bridgesampling R package (Gronau et al. 2017a, b). The
Bayes factor BFi0 expresses the evidence in the data for
including a particular set of covariates (i.e., the covariates
in model Mi) against excluding these covariates (i.e., the
baseline model M0). When BFi0 > 1, the evidence is in
favor of including the covariates. When BFi0 < 1, the evi-
dence is in favor of excluding the covariates. The catego-
ries of Jeffreys (1961) are used as benchmarks for the in-
terpretation of the amount of evidence. A Bayes factor
greater than 3 or else less than 1/3 represents moderate to
substantial evidence, conversely, anything between 1/3 and
3 is only weak or insubstantial evidence. We report the
Bayes factors for the different models in comparison to
M0. By transitivity, we may compute other Bayes factor
of interest. For instance, the Bayes factor BF32, which
compares model M3 with model M2, may be computed
as:
BF32 ¼ BF30BF20 ¼
p datajM3ð Þ
p datajM0ð Þ
p datajM 2ð Þ
p datajM 0ð Þ
¼ p datajM3ð Þ
p datajM2ð Þ
Similarly, we find BF0i = 1/BFi0. An additional Bayes
Factor was calculated for model M0 against a null model
predicting a mean study effect size of 0 (i.e., θ = 0, see below),
to quantify the evidence for the effect of condition.
Bayesian Model Specification The models for the cognitive
bias and substance use outcomes were based on the hierarchi-
cal Bayesian t-test approach of Marsman et al. (2017). We
used the Bayesian t-test model formulation of Rouder et al.
(2009), assuming that the observations are normally distribut-
ed, and started with expressing the mean in the control condi-
tion of a particular study as μ− 12σδ and the mean in the train-
ing condition as μþ 12σδ, such that the difference in group
means is equal to σδ. Here μ denotes the overall mean of the
study outcome, σ2 the common variance in the two conditions
and δ denotes a standardized effect size. The idea is to model
the effect sizes across studies hierarchically, that is, model
them as random effects. We followed Marsman et al. (2017)
and assumed that the effect sizes come from a normal distri-
bution with an unknown mean θ and variance (i.e., study
heterogeneity) τ2. Instead of including a random effect for
participants (i.e., modeling the effect of time of measurement),
we used the difference in outcome scores between baseline
and follow-up as the dependent variable, with positive values
indicating a decrease in the outcome (i.e., a decrease in the
strength of the targeted cognitive bias towards substance-
related cues relative to control cues, or in substance use),
which is in line with the Bayesian paired samples t-test ap-
proach by Rouder et al. (2009).
Including participant-level and study-level covariates ex-
tends the basic model M0 that we described above. At the
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study level, this implies that the prior mean θ on the effect size
of a study s is replaced by θ +∑iγixis, where xis denotes the
value for covariate i of study s and γi the associated regression
coefficient. Similarly, means at the participant-level are ex-
tended by covariates associated to individual outcomes, and
the mean for a participant p in the control condition of a study
s is given by
μs þ σs ∑ jβ jyjps−δs
1
2
 
;
while the mean for a participant p in the training condition is
μs þ σs ∑ jβ jyjps þ δs
1
2
 
:
Here yjps denotes the value for covariate j of participant p in
study s and βj is the associated regression coefficient, where βj
are standardized effects.
The relapse model is a binary outcome analogue for the
models of cognitive bias and substance use. The primary dif-
ference was that a logistic regression model was used as a
starting point with the goal of predicting the chance of relapse.
The mean in the control condition of a particular study was
then modeled as μ− 12 δ and the mean in the training condition
as μþ 12 δ. Note that there was no common variance assumed
in the logistic regression model. Apart from that, the relapse
model was exactly the same and followed the same steps as
the models that were used for the cognitive bias and substance
use outcomes.
To complete the Bayesian hierarchical models, we used
standard non-informative (Jeffreys’s) priors on the mean μs
and variance σ2s of a study s (note that σ
2
s was not used in
the relapse model), that is, p μs;σ
2
s
 
∝σ−2s . For the study-level
variance τ2, we used a half-Cauchy prior with scale set to five,
whereas for the overall mean θ, the participant-level covariates
β, and the study-level covariates γ, we used scaled Cauchy
distributions. For the Cauchy priors on the overall mean and
the regression coefficients, we have used a scale of 1.0.
Given that Bayesian parameter estimation and testing
are sensitive to the specification of the prior distribution,
we included a sensitivity analysis for each outcome, esti-
mating all models with a narrower (scale of 0.5) and wider
(scale of 2.5) prior on the overall mean and the regression
coefficients, hence predicting that relatively large effects
are very uncommon and very common, respectively (i.e.
is, a prior with scale 2.5 assigns more mass to extreme
values than a prior with scale 0.5, which concentrates its
mass more on values close to zero). For each outcome, we
then plotted the Bayes factors for each model against the
baseline model M0 computed by using the three different
priors.
Supplementary Analyses
The two existing CBM meta-analyses were both carried out
within the frequentist statistical framework (Cristea et al.
2016; Mogoaşe et al. 2014). For consistency, we also ran the
same hierarchical models within the frequentist framework.
The detailed description of the one-stage individual patient
data frequentist meta-analysis and of the results is reported
in the Supplementary Material.
Data Availability
Due to the confidentiality and sensitive nature of the collected
data, the dataframes including the individual patient data cre-
ated for the analyses, cannot be shared open access and are
available only upon request. The dataframes are solely usable
to reproduce the results of the current meta-analysis or to
update the meta-analysis to include additional studies pub-
lished after May 2016. The dataframes will be provided solely
under the condition that they cannot be distributed to other
parties nor shared open access. For more information about
the single studies or to access the individual raw datasets
please contact the study authors.
All scripts for both the Bayesian and frequentist analyses
are available open access on the Open Science Framework
platform at https://osf.io/dbcsz/.
Results
Study Selection and Individual Patient Data Obtained
The systematic search resulted in 14 eligible studies out of 2579
search results screened (reference list of included studies report-
ed in Supplementary Material). During the screening process a
few conference abstracts could not be matched to a published
study. The authors of these conference abstracts were contacted
and one additional study was identified through this process.
The remaining conference abstracts were associated to previous
or later peer-reviewed publications. We obtained individual pa-
tient data from all 14 eligible studies, yielding a total of 2435
participants. Figure 1 shows the study selection process.
Study and Participants Characteristics
Half of the studies targeted alcohol use disorders or prob-
lem drinking and the other half tobacco use disorders.
Seven studies included an Attentional Bias Modification
intervention delivered with an adjusted version of the
Visual Probe Task (n = 6) or another training paradigm
based on the emotional Stroop task, the Alcohol
Attention-Control Training Programme (AACTP, n = 1;
Cox et al. 2015). Six studies deployed an Approach Bias
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Modification intervention exclusively delivered with the
Approach Avoidance Task, and one study included both
Attentional Bias Modification and Approach Bias
Modification delivered with the AACTP and Approach
Avoidance Task training paradigms, respectively (Wiers
et al. 2015a, b). No included study targeted evaluative as-
sociations or cue-specific response inhibition (Evaluative
Conditioning or Selective Inhibition Training), since all these
studies were proof-of-principle studies without a behavior
change goal (see Allom et al. 2016 and Jones et al. 2016 for
syntheses of the results of these proof-of-principle studies).
Most studies involved a parallel-group experimental
design, testing the CBM intervention against a control
condition, both in combination with TAU (n = 8). Two
studies tested the combination of Attentional Bias
Modification with another training (Clerkin et al. 2016)
or a motivational intervention (Cox et al. 2015) in a fac-
torial design. Three of the 14 studies ran online and tested
one (Elfeddali et al. 2016; Wittekind et al. 2015) or mul-
tiple CBM training varieties (Wiers et al. 2015a, b) as
stand-alone interventions. The most used control condi-
tion was a sham version of the CBM training (n = 9), in
the form of a continued assessment using the same task.
One study used a placebo training with a different task
(Schoenmakers et al. 2010). Three studies included a no-
training or wait-list control group (Cox et al. 2015; Eberl
et al. 2013; Wittekind et al. 2015), while one study in-
cluded both types of control condition and found no dif-
ferential effects on the primary outcomes (Wiers et al.
2011). The majority of studies comprised multiple ses-
sions of CBM (from 3 to 12), except for two delivering
one session (McHugh et al. 2010; Wittekind et al. 2015).
A description of the main characteristics of each study is
presented in Table 1.
Mean age of the 2435 included participants was 42.37
(SD = 12.13, range = 13–80); 1352 (55.5%) were male.
Fig. 1 PRISMA-IPD study
selection flow
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All studies included participants selected based on a clin-
ical diagnosis of substance use disorder or on patterns of
substance consumption indicative of abuse. The mean se-
verity of substance use problems was 4.62 (SD = 2.38,
range = 0–10) on the FTND for tobacco studies and
23.18 (SD = 8.05, range = 0–40) on the AUDIT, 43.15
(SD = 27.24, range = 5–128; Clerkin et al. 2016) on the
Drinker Inventory of Consequences, and 12.49 (SD =
8.44, range = 0–42; Cox et al. 2015) on the Short Index
of Problems, for alcohol studies. The amount of training
sessions across studies ranged from 1 to 12, while the
amount of training trials per session from 100 to 573.
When data were available, participants completed on av-
erage a total of 1006.72 (SD = 827.08) training trials, in-
dependently from the training condition they were
assigned to, which is equivalent to a mean of 5.03 ses-
sions including 200 trials per session.
Risk of Bias Assessment
Study quality varied over the items of the Cochrane risk of
bias tool but there was generally a low risk of bias (see Fig. 2
for the risk of bias summary graph and Table S10 in the
Supplementary Materials for a detailed overview of the infor-
mation supporting risk of bias judgments for each criterion
across all studies). A study was evaluated as having an unclear
risk of bias for one or more items when the information pro-
vided in the paper or by the authors was not sufficient to make
a judgment. For several studies (n = 9) the assignment of par-
ticipants to the condition was random or randomly stratified.
Four studies used an assignment strategy that did not involve a
random component, while for one study the provided infor-
mation was not sufficient to make a judgment. Only half of the
studies (n = 7) implemented a successful concealment of the
randomization sequence, while in six this was not done or was
not possible. Though all participants were aware that the goal
of the intervention was behavior change, blinding of partici-
pants and study personnel to the allocation of condition was
implemented in most studies (n = 11). The risk for assessor
(detection) bias in both cognitive bias and behavioral out-
come(s) was generally low (n = 12 for both outcomes).
Cognitive bias(es) were assessed with reaction-time comput-
erized tasks, and substance use with self-report measures.
Following the Cochrane guidelines, studies not addressing
an outcome included in the meta-analysis were evaluated as
having an unclear risk of performance bias for that outcome
(n = 2 for cognitive bias and n = 1 for substance use out-
comes). Eight and nine studies used some form of imputation
or coding criteria to handle missing data in the cognitive bias
and behavioral outcomes, respectively, or differences in attri-
tion between conditions were non-significant, indicating a low
risk of attrition bias for both types of outcomes in only 57 and
64% of the studies. For each outcome, three studies included
completers only or applied stringent exclusion criteria without
running sensitivity analyses, resulting in a high risk of bias.
Finally, nine studies were evaluated as having a low risk of
reporting bias due to either the presence of some form of pre-
registration of the study outcomes (e.g., protocol article or
registration in official registry of randomized clinical trials)
or through formal confirmation from the authors. Five studies
did not include one or more outcomes in the final report and
have been evaluated at high risk for reporting bias.
One-Stage Bayesian Individual Patient Data
Meta-Analysis
Change in Cognitive Bias Figure 3 shows the forest plot of the
effect sizes δ separately for each of the 18 comparisons in the
baseline modelM0 of the cognitive bias outcome. The estimat-
ed effect sizes were generally small, and many comparisons
Fig. 2 Summary of the risk of bias evaluations for the 14 included studies. Note that the evaluation of attrition bias for the substance use outcome
includes both reduction in substance use and relapse rate outcomes
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yielded credible intervals that were relatively wide—an indica-
tion that there remains considerable uncertainty about the true
value of the effect size. With small average effects and wide
credible intervals, only four out of the 18 comparisons 95%
central credible intervals did not overlap with zero. The overall
effect size θ for the baseline modelM0 was small, the posterior
mean was equal to 0.23 with a 95% credible interval ranging
from 0.06 to 0.41. Similarly, the between comparison hetero-
geneity τ2 was also small with a posterior mean equal to 0.09
and a 95% credible interval ranging from 0.02 to 0.25. The
Bayes factor of the null model without including the effect
of condition against model M0 was equal to 0.47, showing
that there is no substantial evidence in favor or against either
model.
Table S1 in the Supplementary Materials includes the pa-
rameter estimation results for models M0 to M6 in the
cognitive bias outcome analysis. The overall effect size θ
remained small for each of the six models. Furthermore, there
was a small negative effect for type of addiction of about
−0.20 in modelsM3 toM6, which implied that the effect sizes
in alcohol CBM studies were slightly larger, on average, than
tobacco studies. Note that the effect of type of addiction was
roughly the same as the overall effect size, which implies that
the expected effect in tobacco studies is about zero and the
expected effect for alcohol related comparisons is about 2θ ≈
0.4. All other effects were small, negative and uncertain, with
posterior means ranging from −0.11 to −0.03 and 95% credi-
ble intervals overlapping with zero.
Table S1 also shows the log Bayes factor for each of the six
models, comparing their predictive accuracy against model
M0. All log Bayes factors were negative (i.e., Bayes factor <
1), expressing evidence in favor of model M0. There was a
Fig. 3 Results of the Bayesian
parameter estimation of the effect
sizes δ for each of the 18
comparisons included in the
analysis of the cognitive bias
outcome. The effects sizes were
estimated using the baseline
model M0. The posterior means
are indicated as dots and the 95%
central credible intervals as
horizontal lines
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substantial amount of evidence against models M3, M4, M5
and M6, and in favor of the baseline model M0. For example,
it is about e4.32 ≈ 75 times more likely that the data came from
modelM0 instead ofmodelM3. Furthermore, the Bayes factors
for models M1 and M2 are relatively close to zero, which im-
plies that there is little evidence either in favor or against them
in comparison to the basic model M0 (i.e., the log Bayes fac-
tors are between log(1/10) = −2.30 and log(10) = 2.30).
As the aim was to compare different models, which can
be done through transitivity of Bayes factors when com-
puted on the same data, participants with missing values
on the covariates had to be excluded from the analyses.
Since there were no data available on the severity of sub-
stance use covariate for two comparisons (Schoenmakers
et al. 2010), we would have had to exclude these compari-
sons from all analyses in order to compare across models M1
to M7. Instead of excluding the data from these comparisons
across all models, we opted to include all available data across
models M1 to M6 including all comparisons, and estimate
model M7 separately. The 18 comparisons included 3369 ob-
servations for the analysis of cognitive bias data, with 2112
observations without any missing values for the covariates
that were used in the models reported in Table S1. An addi-
tional 92 observations were omitted for the analysis of model
M7, of which 69 came from the two excluded comparisons.
We report the results for model M7 on the reduced dataset
in Table S2 (Supplementary Materials). When comparing the
estimated effects of M7 with the estimated effects of M6 re-
ported in Table S1, we found substantial differences. For in-
stance, the overall effect size and the effect of type of addiction
roughly halved their values, and the 95% central credible in-
tervals for each effect overlapped with zero inM7. Severity of
substance use problems showed almost no effect, with a pos-
terior mean equal to −0.01 and a 95% credible interval ranging
from −0.06 to 0.03. Further, the log Bayes factor strongly
supported the baseline model M0 (both marginal likelihoods
were computed on the reduced dataset). To summarize, CBM
was found to modestly reduce cognitive bias, although this
effect was associated with much uncertainty, and was not af-
fected by moderators, with the exception that reduction in
cognitive bias after the training intervention is more likely to
be observed for bias toward alcohol, but not toward tobacco.
Figure 4 displays the results of the sensitivity analyses car-
ried out with the two additional prior distributions. The Bayes
Factor for modelsM1 –M6 (against modelM0) further corrob-
orate the lack of evidence for the inclusion of any of the
covariates and moderators in models M1 to M6, relative to
the simpler model M0, since they all range in the region of
acceptance of H0 (i.e., model M0 is more plausible). The pat-
tern of results is not different when using a narrower or wider
Fig. 4 Sensitivity analysis of
cognitive bias outcome showing
Bayes factors for modelsM1 –M6
against model M0 computed with
the three different prior
distributions on the main
parameters of interest: primary
prior distribution (scale of 1;
circle), wider prior (scale 2.5;
triangle) and narrower prior (scale
0.5; square). The direction of the
hypothesis refers to the two-sided
BF10. The top margin indicates
the evidence categories proposed
by Jeffreys (1961)
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prior, as shown by the monotonic relationship of Bayes factors
values across all models. Due to the different number of ob-
servations included in modelM7, the same sensitivity analysis
was conducted separately, with a similar trend in the results.
Reduction of Substance Use Figure 5 shows the forest plot for
the effect sizes δ separately for each of the seven comparisons
in the baseline model M0 for the reduction in substance use
outcome. With the exception of the study by Wittekind et al.
(2015) the estimated effect sizes were all small, with many
studies yielding relatively wide credible intervals. Two out of
the seven 95% central credible intervals did not overlap with
zero. The overall effect size θ in the baseline model M0 was
small, the posterior mean was equal to 0.19 with a 95% central
credible interval ranging from −0.23 to 0.58. The between
study heterogeneity τ2 was also found to be small with a
posterior mean equal to 0.22 and a 95% credible interval rang-
ing from 0.01 to 1.20. The Bayes factor for the null model not
including the effect of condition against model M0 was equal
to 3.06, showing that there is moderate evidence against M0.
The parameter estimation results for models M1 to M6 in
the reduction of substance use analysis are reported in detail in
Table S3 in the Supplementary Materials. In each of the six
models the overall effect size θ remained small. Moreover,
even though several small effects were estimated, e.g., amount
of completed training trials, the 95% central credible interval
for each effect was relatively wide and overlapped with zero.
The log Bayes factors that are reported in Table S3 are in line
with these results. Except for the Bayes factor contrasting
models M1 and M0, which reveals little evidence in favor or
against model M1 when compared to M0, all Bayes factors
show strong support for the baseline model M0.
Fig. 5 Results of the Bayesian
parameter estimation of the effect
sizes δ for each of the seven
comparisons included in the
analysis of the substance use
outcome. The effects sizes were
estimated using the baseline
model M0. The posterior means
are indicated as dots and the 95%
central credible intervals as
horizontal lines
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Similar to the cognitive bias outcome, we analyzed M7
separately (see Table S4 in the Supplementary Materials).
The seven comparisons for the substance use outcome includ-
ed 1064 observations, with 768 observations having no miss-
ing values for the covariates used in the models reported in
Table S3. An additional eight observations were omitted for
the analysis of modelM7 due tomissing data on the severity of
substance use covariate.
The estimated effects of M7 were similar to the estimated
effects of M6 reported in Table S3. We found a small main
effect of severity of substance use (its posterior mean was
equal to 0.18 with a 95% central credible interval ranging
from 0.11 to 0.26), indicating a positive relationship between
the increase in severity of substance use problems and in-
crease in consumption at follow-up. The reported log Bayes
factor also suggested that there was substantial evidence to
include the effect of severity of substance use in M7 relative
to model M6. The relative predictive adequacy of the most
complex model including the effect (model M7), compared
to the simplest model excluding the effect (model M6), was
computed as follows
BF76 ¼ BF70BF60 ¼
p data j M 7ð Þ
p data j M 0ð Þ
p data j M 6ð Þ
p data j M 0ð Þ
¼ p data j M 7ð Þ
p data j M 6ð Þ :
Based on the log Bayes factor values reported in Tables S3
and S4, logBF76 = e
−0.11 + 8.19 ≈ 3,229.23, which indicated
overwhelming evidence in favor of including the covariate
effect of severity of substance use problems. Moreover, this
comparison assumed that the removal of the cases with miss-
ing data on the severity of substance use covariate could be
safely ignored. Another way of expressing the evidence is to
argue that there was substantial evidence against including
any of the effects in model M6 in Table S3, while this is
certainly not the case for the effects in model M7 reported in
Table S4. In short, although a main effect of severity of
substance use was identified, the Bayesian analysis of the
substance use outcome showed no reliable evidence in
support for a differential effect of training condition over
the decline in substance use between baseline and follow-
up.
Figure 6 displays the results of the sensitivity analyses car-
ried out with the two additional prior distributions. The Bayes
factor for modelsM1 –M6 (against modelM0) further corrob-
orate the lack of evidence for the more complex models since
all Bayes factors indicate evidence in favor of H0 (i.e., the data
are more plausible under M0). The pattern of results is not
different when using a narrower or wider prior, as shown by
the monotonic relationship of Bayes factor values across all
models. The same sensitivity analysis for modelM7 showed a
similar trend.
Fig. 6 Sensitivity analysis of
reduction in substance use
outcome showing Bayes factors
for modelsM1 –M6 against model
M0 computed with the three
different prior distributions on the
main parameters of interest:
primary prior distribution (scale
of 1; circle), wider prior (scale
2.5; triangle) and narrower prior
(scale 0.5; square). The direction
of the hypothesis refers to the
two-sided BF10. The top margin
indicates the evidence categories
proposed by Jeffreys (1961)
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Relapse Rate Figure 7 shows the forest plot of the log odds
difference δ between the training and the control condition for
each of the eight comparisons for the relapse outcome. All
estimated effects were negative, indicating that there was a
positive effect of training (i.e., a lower probability of relapse),
yet all of the 95% central credible intervals overlapped with
zero. The overall effect θ was also small and negative, the
posterior mean was equal to −0.27 with a 95% credible inter-
val ranging from −0.68 to 0.22. The between study heteroge-
neity τ2 was also small with a posterior mean equal to 0.21 and
a 95% credible interval ranging from 0.01 to 1.15. The Bayes
factor of for the null model not including the effect of condi-
tion against modelM0 was equal to 2.06, showing that there is
no substantial evidence in favor of either model.
The parameter estimation results for models M0 to M6 re-
vealed a main positive effect of number of training trials and a
negative interaction effect with training condition on the prob-
ability of relapse in modelM6 (estimates are reported in detail
in Table S5 in the Supplementary Materials). The posterior
mean of the log odds for the main effect of number of training
trials was equal to −1.29 with a 95% central credible interval
ranging from −1.89 to −0.66, while the posterior mean of its
interaction with condition was equal to 0.88 with a 95%
credible interval ranging from 0.27 to 1.54. Even though
there is still much uncertainty in both effects, it appears
that completing more training trials leads to 72% lower
probability of relapse. However, when considering the
interaction effect with the training condition, this effect
seemed to be attenuated in the training condition, which
showed [(e( − 1.29 + (.87 × 0.5)) − 1] ∗ 100 ≈ 57% lower chance
of relapse as the amount of completed training trials
Fig. 7 Results of the Bayesian
parameter estimation of the mean
log odds difference δ between
training and control condition for
each of the eight comparisons
included in the analysis of the
relapse outcome. The intercepts
were estimated using the baseline
model M0. The posterior means
are indicated as dots and the 95%
central credible intervals as
horizontal lines
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increases, while the control condition showed [(e( − 1.29 +
(.87 × − 0.5)) − 1] ∗ 100 ≈ 82% lower chance to relapse.
All other effects, except for number of training trials inM5
and its interaction with condition inM6, showed 95% credible
intervals overlapping with zero. Interestingly, there is evi-
dence in favor of including both the effect of the amount of
completed training trials, as for its interaction with condition.
Based on the log Bayes factor values in Table S5 we found
BF54 = e
−1.36 + 5.14 ≈ 43.81 and BF65 = e1.47 + 1.36 ≈ 16.95, both
indicating support for including the effect.
Also for relapse rate, we analyzed model M7 separately
from modelsM1 toM6. The eight comparisons for the relapse
outcome included 1424 observations, of which 1411 with no
missing values for the covariates were used in the modelsM1
to M6 reported in Table S5. An additional 54 observations
were omitted for the analysis of model M7.
Table S6 reports the results for model M7 after ex-
cluding these observations. The estimated effects of M7
were very similar to the estimated effects of M6. The
effect of severity of substance use was very small with
a posterior mean equal to 0.13 and a 95% central cred-
ible interval ranging from −0.01 to 0.26. Since the
Bayes factors in Table S5 and Table S6 have been
computed on different datasets the comparison of their
values should be done with caution. The Bayes factor in
Table S6 suggests that there is no evidence in favor or
against M7 when compared to the baseline model M0.
Further, the amount of evidence is lower than the
amount of support that M6 received. This result suggests
that there is no evidence for the inclusion of addiction
severity. In sum, the Bayesian analysis showed a small
albeit unreliable effect of CBM on relapse and a posi-
tive moderation effect of the amount of trials completed
by participants. However, this moderation effect was
stronger in the control condition, with a greater reduc-
tion in relapse rate for the control relative to the train-
ing condition. Yet, there is no substantial evidence
against or in favor of these effects.
Figure 8 displays the results of the sensitivity analyses car-
ried out with the two additional prior distributions. The Bayes
factor for modelsM1 –M5 (against modelM0) corroborate the
lack of evidence for such models since all Bayes factors range
in favor of H0 (i.e., data are more plausible under M0).
However, in line with the parameter estimate results, the in-
clusion of the moderation effect of amount of completed train-
ing trials shifted the evidence in favor of model M6. The pat-
tern of results is not different when using a narrower or wider
prior, except for a spreading effect towards more extreme
values (as implied by using a narrower and wider prior distri-
bution for the mean effect and regression coefficients). The
same sensitivity analysis for modelM7 showed a similar trend
of results as for model M6.
Fig. 8 Sensitivity analysis of
relapse outcome showing Bayes
factors for models M1 – M6
against model M0 computed with
the three different prior
distributions on the main
parameters of interest: primary
prior distribution (scale of 1;
circle), wider prior (scale 2.5;
triangle) and narrower prior (scale
0.5; square). The direction of the
hypothesis refers to the two-sided
BF10. The top margin indicates
the evidence categories proposed
by Jeffreys (1961)
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Supplementary Analyses
The one-stage frequentist individual patient data meta-
analysis included the estimation of models M0 to M6 on the
same dataset for the three outcomes. A detailed description of
the data analysis and of the results is reported in the
Supplementary Materials. The analysis of the cognitive bias
outcome evidenced a small effect of training condition on the
change in cognitive bias from baseline to post-intervention (β
range = 0.10–0.14, p’s ≤ .01; Table S7). This effect was not
affected by any of the study- or participant-level covariates
or moderators. No significant effect of condition on the differ-
ence in substance use between baseline and follow-up was
found (Table S8). For relapse rate, the results appeared to be
more complex (Table S9). The most complex model
M7 showed the best fit to the data, including a main effect of
type of addiction (higher chance of relapse for tobacco use
disorder) and type of CBM training (lower chance of relapse
when deploying Approach Bias Modification training) on re-
lapse rate, but no significant effect of condition on relapse rate.
Note that in this model two comparisons were not included
due tomissing data. However, similar results were observed in
the next best fitting and more parsimonious modelM5, includ-
ing all study comparisons. Training condition significantly
affected relapse rate only in those models that did not include
the number of completed training trials as a covariate (i.e.,
models M0, M1, M2, M3 and M4), all indicating around 16%
lower chance to relapse in the training group (ORs ≈ 0.84, ps
< .05). However, these models showed a very poor fit to data.
Discussion
In this study, we examined the effectiveness of CBM interven-
tions for addictive behaviors, specifically for the treatment of
alcohol and tobacco use problems, by conducting a meta-
analysis of studies explicitly testing CBM as a behavior
change intervention with the targeted recipient population
(i.e., individuals with a clinical diagnosis of substance use
disorder or suffering from substance use problems who were
aware that the goal of the intervention was behavior change).
The goal of the meta-analysis was twofold. First, we aimed at
testing whether CBM interventions have a global impact on
both the targeted cognitive bias(es) and on substance use be-
havior, in terms of reduction in drug consumption and relapse
rate. Second, given the variety of CBM paradigms, training
program characteristics and dosages, and differences across
people meeting criteria for alcohol use disorders, typically
patients with comorbid problems, and tobacco use disorders,
typically well-functioning adults who have a problem quitting
smoking, we aimed at evaluating the impact of relevant co-
variates and moderators of CBM interventions effects. To this
aim, we conducted an individual patient data meta-analysis to
test a series of hierarchical models progressively including
multiple study- and participant-level moderators of CBM ef-
fect sizes. Additionally, we conducted the meta-analysis in the
Bayesian statistical framework, in order to explicitly quantify
and test the available evidence in favor or against CBM.
In the 14 studies meeting the eligibility criteria, CBM in-
terventions were found to have a small, albeit unreliable, over-
all effect on cognitive bias directly after the completion of the
training intervention. When the goal was reducing substance
use, no differential effect on substance use was observed,
whereas when the outcome was abstinence, an overall small,
albeit very uncertain, effect was observed in the medium-to-
long term, as demonstrated by the extremely wide 95% cred-
ible intervals of the effect sizes in the Bayesian results.
When examining the effect of the covariates and related
interaction effects with training condition, very weak evidence
was found regarding the inclusion of covariates and modera-
tors in the models, as shown by the majority of Bayes factors
favoring the simplest models excluding all moderators. None
of the moderators appeared to have a substantial impact on the
CBM effects on the outcomes, with the exception of amount
of completed training trials in the relapse analyses. The latter
moderator was added to account for the individual variability
in training adherence, but also to account for the inter-study
variability in the amount and length of training sessions of the
included studies, as shown in Table 1. The inclusion of such
moderator was also in line with the results of a post-hoc fol-
low-up study of Eberl et al. (2014), which re-analyzed a sub-
set of participants in Eberl et al. (2013) and showed large
individual differences in learning effects along multiple ses-
sions, emphasizing the importance of including at least five
sessions of training when delivering an Approach Bias
Modification intervention.
Indeed, the amount of completed training trials appeared
to both improve the likelihood of the data under the specified
model M6, outperforming the baseline model M0, and to
moderate the effect of CBM on relapse rate. Specifically,
although completing more training trials appeared to reduce
the chance of relapse, when examining the effect of the inter-
action with training condition, it appeared that it might actu-
ally result in larger effects in the control condition, thus re-
ducing, by comparison, the beneficial effects of the real train-
ing (i.e., smaller decrease in the chance of relapse in the
training compared to the control condition). Note that in the
same analyses carried out with the frequentist approach (see
Supplementary Material), the amount of completed training
trials variable appeared to be irrelevant despite increasing the
goodness of fit of the models including it, since it did not
substantially affect the training condition effects on the re-
lapse outcome (OR’s = 1.00). As a matter of fact, in the
frequentist analysis of relapse rate, the effect of training con-
dition disappeared after the inclusion of the main and inter-
action effects of amount of training trials in modelsM5 toM7,
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whereas it was still significant in the simpler models M0 to
M4.
In ten out of the 14 studies, participants assigned to the
control condition completed a sham training, which exposed
them to the same substance-related and neutral stimuli pre-
sented in the training condition, though with no stimulus-
response contingency (e.g., a continuous assessment task with
substance-related and neutral stimuli pulled and pushed equal-
ly often). The results seem to suggest that the continuous
exposure to the same substance-related stimuli presented with-
out any task contingency may induce a greater decrease in the
chance of relapse for participants in the control condition,
compared to those completing the active CBM training. Due
to the absence of any relation between stimulus category and
the actual task response, that is, stimuli are equally pushed and
pulled in Approach BiasModification or equally replaced by a
probe in Attentional Bias Modification trainings, it may be
possible that participants in the control condition learn to ig-
nore the contents of the stimuli presented and simply focus on
performance, which in turn may translate into a lower reactiv-
ity toward triggers of substance use behavior. This hypothesis
suggests that there might be two mechanisms at work in
CBM, firstly, an active re-training mechanism, where the
dominant cue-induced response-tendency is changed to anoth-
er dominant response-tendency, which appears to happen
quickly–as shown by the small CBM effect on changes in
cognitive bias at conclusion of the intervention–, and a more
general extinction-like process making patients less sensitive
to the motivational meaning of the addiction-relevant cues (cf.
den Uyl et al. 2017). Testing this hypothesis would require a
study design focussing on both the clinical effectiveness and
working mechanisms of CBM, by comparing a CBM inter-
vention against both an (active) sham training control and a
full control condition with no training (e.g., treatment as usu-
al), and by evaluating potential mediation effects of changes in
cue reactivity towards substance-related cues across the three
conditions. Note that one of the largest studies included in the
meta-analysis originally contrasted an Approach Bias
Modification training against two such control conditions,
with no differential effect on the outcomes, although no as-
sessment of cue reactivity was included (Wiers et al. 2011);
hence, the control conditions were merged in the current meta-
analysis.
Although the majority of included studies used a sham
training as comparator, one of the four remaining studies used
a different placebo task unrelated to the training paradigm,
while three included a no-training or wait-list condition, with
participants completing zero training trials. The large amount
of zeros observed in the amount of completed training trials
variable for the latter three studies, may have biased its mod-
eration effects of including condition, due to a possible under-
lying confounding effect of different control conditions.
Further, some studies had some missing data points in this
moderator–,which led to the exclusion of 133 observations
for the model including it, and in some studies all participants
completed the same amount of training sessions, decreasing
the degree of variability in the data. Due to the small number
of studies, it was not possible to add type of control condition
as an additional study-level moderator, which could have clar-
ified the difference in the comparator condition and shed light
on the hypothesis of different working mechanisms at play in
the sham training condition. Further, we could not run a sen-
sitivity analysis excluding the studies using a different control
condition due to the additional loss in cases, which would
further reduce the amount of available evidence for the main
intervention effect.
Although interesting from a theoretical and experimen-
tal point of view, the considerable uncertainty associated
with these results prevents definite conclusions.
Nonetheless, the choice of the optimal comparator in ef-
fectiveness studies plays a crucial role in estimating the
true effects of an intervention (Blackwell et al. 2017;
Hertel and Mathews 2011). A sham version of the CBM
training would at first sight seem to be the ideal comparator
to evaluate the relative efficacy of CBM, as it allows the
researcher to isolate the underlying alleged training mech-
anism, while keeping the procedural features and exposed
contents of the training constant (i.e., minimal credible
intervention). However, such a control condition may be
sensitive to effects of general exposure mechanisms and
extinction-like or desensitization learning processes, as
mentioned above. Moreover, there may be placebo- or
nocebo-effects at play (note that for Attentional Bias
Modification, participants in both conditions typically
believe they are in the control condition, and experience
the training as rather meaningless, Beard et al. 2011). This
is an issue for clinical applications of CBM programs. One
approach could be to explain the idea behind CBM, but
there is some evidence from anxiety treatment studies that
this might be counterproductive (Grafton et al. 2014), al-
though in the addiction field no differences were found
between a more and less explicit experimental condition
(Wiers et al. 2011). One issue with this approach relates
to the blinding of conditions as is preferred in clinical re-
search (Boutron et al. 2008; Schulz and Grimes 2002;
Wiers et al. 2018). In addition, the contents of CBM could
be better aligned to the contents of the accompanying ther-
apy, typically cognitive behavioral therapy, by personaliz-
ing not only the addiction-relevant cues, but also the alter-
natives (see Kopetz et al. 2017, for a proof-of-principle
study). However, this approach will further complicate
blinding.
An additional concern is related to the fact that even in a
between-subject design, the contents of the control condition
(i.e., sham training) may not be sufficiently contrasted with
that of the training condition, which may induce a certain lack
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of differentiation (i.e., dependence) between these two condi-
tions. For example, if the procedural features between the
active training and the sham training are too similar to each
other, in addition to not detecting a differential effect between
the two, we may consider that they are so similar that scores
on one condition may predict scores on the other condition, or
that the chance of detecting an already small training effect is
further shrunk by a “diluted” training effect in the sham con-
dition, due to the exposure of addiction-relevant stimuli in the
trained-response format in half of the trials (e.g., avoid re-
sponse in Approach Bias Modification or shift attention away
in Attentional Bias Modification; cf. Salemink et al. 2014).
The latter situation falls within the broader discussion into
the selection of the most appropriate control comparator based
on the research question of interest, which highlights the in-
efficiency and poor utility of sham training as a truly neutral or
placebo comparator when addressing the clinical utility of
CBM (Blackwell et al. 2017; Kakoschke et al. 2018), due to
the potential, albeit “diluted” active effects mentioned above.
Testing specific training mechanisms underlying therapeutic
effects, evaluating the efficacy of CBM as an adjunct inter-
vention added to an existing treatment, or as a first line low-
threshold intervention program, are different research ques-
tions implying different choices in terms of what the appro-
priate control condition should include (for an extensive
discussion see, Blackwell et al. 2017).
Despite the small effects on cognitive bias and relapse in both
statistical frameworks, these effect sizes were found to be ex-
tremely unreliable and uncertain. Indeed, the amount of CBM
studies qualifying as “true” behavior change studies is still very
small (n = 14), with consequent limited and inconsistent empir-
ical evidence in favor or against CBM, as confirmed by the
values of Bayes factors for the simplermodel including the effect
of training condition. During the selection process we excluded
23 additional CBM studies because they were not set up to
evaluate the therapeutic effects of CBM as a behavior change
intervention. In many of the screened CBM reports the presen-
tation of the study was ambiguous and it had been necessary to
contact the authors asking clarifications about the original goal
of the study: whether the primary focus of the respective study
was aimed at testing mechanisms of bias-change (proof-of-
principle studies in students), or whether it was behavior
change (often in patients, but in some cases also in students).
Hence, for future studies, it would seem imperative to clearly
define the primary goals as clinical or experimental (cf.,
Wiers et al. 2018).
A last remark addresses an often-overlooked CBM training
parameter, that is, the interval between training sessions.
Learning and consolidation effects are not only dependent on
on-line learning, that is, within-session active learning based on
repetitive practice, but also on off-line learning processes, name-
ly, between-session passive learning based on consolidation pro-
cesses. Therefore, the time interval between training sessions is
very likely to play a role in the consolidation of the training
effects in the long-term memory (e.g., Abend et al. 2014).
Unfortunately, the schedule of training sessions and the evalua-
tion of participant adherence to training schedules has not been
systematically addressed in both the design of CBM training
protocols and the evaluation of their effects, which limits the
exploration of the effects of this additional study-level parameter
into an aggregate analysis of CBM effects.
In contrast to the substantial number of proof-of-principle
studies, it is evident that clinical research in this field is still in
its infancy and, as yet, has not provided enough evidence to
give a reliable response regarding the effectiveness of this
class of intervention, consistent with existing narrative re-
views of selected CBM programs or targeting one particular
addictive behavior (Christiansen et al. 2015; Mühlig et al.
2017; Wiers et al. 2018). Further, training protocols of
CBM are not consistent, with different amounts of sessions
and trials per sessions, inclusion of filler trials mixed with
training trials, different instructions or training task parame-
ters (e.g., stimulus onset asynchrony), different intervention
settings, and so on. These differences across training pro-
grams can create problems in both the inclusion and compar-
isons across studies since it would imply the addition of too
many study-level moderators to adequately model sources of
variance other than the primary therapeutic effects, for which
there are not enough observations. In fact, we could not in-
clude one of the planned moderators, that is, training setting,
in the analyses, due to the inclusion of only three studies
conducted in an unsupervised environment (Elfeddali et al.
2016; Wiers et al. 2015b; Wittekind et al. 2015).
It is then crucial for the successful reproducibility of results
and advance in the accumulation of evidence on the clinical
efficacy of CBM to 1) endorse a systematic design and
reporting of results of CBM behavior change studies as for
other treatment interventions (e.g., CONSORT guidelines,
Boutron et al. 2008, 2017), and including measures of training
adherence as part of intervention outcomes; 2) share CBM in-
tervention protocols and systematically test any change to pro-
cedure or contents before deploying such protocols into full
treatment programs, since more studies are necessary to ensure
the reproducibility of robust effects of the same treatment pro-
tocol; 3) carefully consider the selection of the intervention
comparison (i.e., control condition) based on the research ques-
tion at hand, and 4) increase the study quality, since despite the
overall quality being generally high, some methodological is-
sues in the studies included in this meta-analysis are likely to
have introduced sources of bias. These issues related particu-
larly to the generation of the randomization sequence and the
related concealment of treatment allocation, which were not
applied or guaranteed in almost half of the included studies.
Robust methods of randomization in trials are essential to min-
imize allocation and selection bias and are technically easy to
implement in the case of computerized interventions such as
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CBM training programs, since software used to implement and
deliver the training program can also automatically randomize
participants independently from the study personnel, who are
then kept fully blinded to the assigned conditions and cannot
predict the next participant assignment.
A last limitation affecting the quantitative aggregated anal-
ysis is the dependency between some of the included compar-
isons. Some studies included non-independent observations,
for example by using several measures for the same outcome
(i.e., Begh et al., 2015; Eberl et al. 2013; Schoenmakers et al.
2010; Wiers et al. 2011) or contrasting multiple CBM inter-
ventions to the same control condition (Wiers et al. 2015b).
This can be problematic, since our statistical tools assume that
analyses are conducted with an independent set of observa-
tions, that is, the value of one observation is not meant to be
affected by the value of another, and that the effect sizes are
independent realizations from a single overarching distribu-
tion. However, in our case, this is unlikely to have any serious
consequences for our conclusions, since the independence of
the observations (or more precisely, of residuals) has the effect
of increasing the risk of error of Type I, namely, to reject the
null hypothesis wrongly. However, more attention should be
paid in future research to the independence of observations
within the same study (i.e., include a within- or a between-
subjects design with a single measure for each outcome).
In conclusion, the results of this meta-analysis confirmed the
absence of enough evidence either in favor of or against of CBM
as a behavior change intervention in alcohol use disorders and
tobacco use disorders. However, based on the limited existing
evidence, CBM has shown a modest impact on reducing the
targeted cognitive bias(es), and, when the goal of the treatment
was full abstinence, some indication of a small effect on the
chance of relapse at follow-up, although with paradoxical effects
with increased training practice. No other study- or participant-
level moderator affected the impact of CBM on the outcomes.
The included studies mainly focused on testing whether CBM
works as a treatment intervention, and not if and under which
circumstances, which would be more in line with an experimen-
tal medicine approach (Sheeran et al. 2017; Wiers et al. 2018).
Indeed, only one study tested a moderated mediation (Eberl et al.
2013) to evaluate the mechanisms of change of the observed
clinical effects, that is, whether the change in the behavioral
outcome was a result of the change in the cognitive process
targeted by the training intervention, and for whom this
occurred. Very little can be said regarding whether CBM
does impact addictive behaviors through changing the
targeted dysfunctional information processing of appetitive
cues in the environment, or if other non-specific compo-
nents of CBM paradigms have an effect, which would
also appear when using a sham version of the training.
Therefore, we do not suggest stopping investigating CBM
as a behavior change intervention, as more evidence is neces-
sary to reach a valid and unequivocal conclusion. However,
we strongly recommend a careful reappraisal of choices in
experimental design and methodology in the shift from the
proof-of-principle, fundamental phase of research on the
mechanisms at work in CBM, to the establishment of its clin-
ical efficacy. Clinical efficacy studies naturally address differ-
ent research questions, thus involving different choices in
terms of study design, but also need to adhere to a stricter
array of methodological standards, as to also efficiently allow
for an integrative synthesis of the available evidence.
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